PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
06-Feb-2026 Ameerex Confirms Major Heavy Rare Earth Mineralization in Brazil JV Across the Goiás-Araxá-Catalão Belt - Brazil Ranking Second to China by Estimated REE Resources ACCESS Newswire
06-Feb-2026 Medical Care Technologies Inc. (OTC PINK:MDCE) is Building an AI Wellness Ecosystem with New Lifestyle Application Category ACCESS Newswire
06-Feb-2026 Rural Health Transformation Funding Raises the Stakes for Rural Hospital Cash Flow as Revenue Cycle Outsourcing Demand Accelerates ACCESS Newswire
06-Feb-2026 Invitation to the Presentation of Cantargia's Annual Results for 2025 ACCESS Newswire
05-Feb-2026 LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories ACCESS Newswire
05-Feb-2026 Medical Care Technologies Inc. (OTC Pink:MDCE) Signals Long-Term Potential to Redefine Consumer Dermatology Standards Through AI ACCESS Newswire
05-Feb-2026 Ayrmid and Ariti Sign Distribution Agreement for Omisirge(R) in Greece and Cyprus ACCESS Newswire
05-Feb-2026 Sacred Connection Launches Comprehensive Educational Guide to Traditional Rapé Medicine ACCESS Newswire
05-Feb-2026 Endomimetics Announces Strategic Restructuring into IP Foundry to Accelerate Bionanomatrix(TM) Clinical Applications ACCESS Newswire
05-Feb-2026 VSEE Health Announces Strategic Managed Services Partnership With GoMyRx, an Affiliate of GoMyDocs, to Accelerate Integrated Digital Healthcare Delivery ACCESS Newswire
05-Feb-2026 Tenon Medical, Inc. Sets Date for Fourth Quarter and Full Year 2025 Earnings, Reaffirms Expected Revenues ACCESS Newswire
05-Feb-2026 Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit ACCESS Newswire
05-Feb-2026 Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging ACCESS Newswire
05-Feb-2026 Microbix Schedules Release of Results for Q1 Fiscal 2026 ACCESS Newswire
05-Feb-2026 Ayrmid Pharma Ltd Announces Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia (SAA) Presented at TANDEM ACCESS Newswire
05-Feb-2026 Zomedica Announces "Fourth Friday at Four" Webinar on February 27th Focused on Research & Development and Its Innovation Pipeline ACCESS Newswire
05-Feb-2026 Invitation to Alligator Bioscience's Earnings Call on 12 February 2026 ACCESS Newswire
05-Feb-2026 BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery ACCESS Newswire
05-Feb-2026 Pentixapharm Announces Peer-Reviewed Phase 2 Data Back Use of PENTIXAFOR as a Superior Non-invasive PET-Diagnostic for Primary Aldosteronism ACCESS Newswire
05-Feb-2026 Spago Nanomedical Year-End Report January-December, 2025 ACCESS Newswire